Global Parkinson Disease Drug Market 2020 by Company, Regions, Type and Application, Forecast to 2025
Summary
Market Overview
The global Parkinson Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Parkinson Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Parkinson Disease Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Parkinson Disease Drug market has been segmented into Sinemet-CR, Trastal, Madopar, COMT Inhibitor, Other, etc.
By Application, Parkinson Disease Drug has been segmented into Under 40 Years Old, 40-65 Years Old, Above 65 Years Old, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Parkinson Disease Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Parkinson Disease Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Parkinson Disease Drug market.
The report offers in-depth assessment of the growth and other aspects of the Parkinson Disease Drug market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Parkinson Disease Drug markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Parkinson Disease Drug Market Share Analysis
Parkinson Disease Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Parkinson Disease Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Parkinson Disease Drug sales, revenue and market share for each player covered in this report.
The major players covered in Parkinson Disease Drug are: Merck, Kyowa Hakko Kirin Pharma, Novartis, Akorn, Abbvie, GSK, Desitin Arzneimittel, Teva Pharmaceutical, Boehringer Ingelheim, Astellas Pharma, Apokyn, US WorldMeds, Endo Pharmaceuticals, Orion, Valeant, F.Hoffmann-La Roche, Bausch Health, Stada Arzneimittel, H.Lundbeck, etc. Among other players domestic and global, Parkinson Disease Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Table of Contents
1 Parkinson Disease Drug Market Overview
1.1 Product Overview and Scope of Parkinson Disease Drug
1.2 Classification of Parkinson Disease Drug by Type
1.2.1 Global Parkinson Disease Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Parkinson Disease Drug Revenue Market Share by Type in 2019
1.2.3 Sinemet-CR
1.2.4 Trastal
1.2.5 Madopar
1.2.6 COMT Inhibitor
1.2.7 Other
1.3 Global Parkinson Disease Drug Market by Application
1.3.1 Overview: Global Parkinson Disease Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Global Parkinson Disease Drug Market by Regions
1.4.1 Global Parkinson Disease Drug Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Parkinson Disease Drug (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Parkinson Disease Drug Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Parkinson Disease Drug Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Parkinson Disease Drug Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Parkinson Disease Drug Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Parkinson Disease Drug Status and Prospect (2015-2025)
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.2 Kyowa Hakko Kirin Pharma
2.2.1 Kyowa Hakko Kirin Pharma Details
2.2.2 Kyowa Hakko Kirin Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Kyowa Hakko Kirin Pharma SWOT Analysis
2.2.4 Kyowa Hakko Kirin Pharma Product and Services
2.2.5 Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.4 Akorn
2.4.1 Akorn Details
2.4.2 Akorn Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Akorn SWOT Analysis
2.4.4 Akorn Product and Services
2.4.5 Akorn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.5 Abbvie
2.5.1 Abbvie Details
2.5.2 Abbvie Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Abbvie SWOT Analysis
2.5.4 Abbvie Product and Services
2.5.5 Abbvie Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.6 GSK
2.6.1 GSK Details
2.6.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GSK SWOT Analysis
2.6.4 GSK Product and Services
2.6.5 GSK Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.7 Desitin Arzneimittel
2.7.1 Desitin Arzneimittel Details
2.7.2 Desitin Arzneimittel Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Desitin Arzneimittel SWOT Analysis
2.7.4 Desitin Arzneimittel Product and Services
2.7.5 Desitin Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.8 Teva Pharmaceutical
2.8.1 Teva Pharmaceutical Details
2.8.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Teva Pharmaceutical SWOT Analysis
2.8.4 Teva Pharmaceutical Product and Services
2.8.5 Teva Pharmaceutical Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Details
2.9.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Boehringer Ingelheim SWOT Analysis
2.9.4 Boehringer Ingelheim Product and Services
2.9.5 Boehringer Ingelheim Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.10 Astellas Pharma
2.10.1 Astellas Pharma Details
2.10.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Astellas Pharma SWOT Analysis
2.10.4 Astellas Pharma Product and Services
2.10.5 Astellas Pharma Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.11 Apokyn
2.11.1 Apokyn Details
2.11.2 Apokyn Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Apokyn SWOT Analysis
2.11.4 Apokyn Product and Services
2.11.5 Apokyn Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.12 US WorldMeds
2.12.1 US WorldMeds Details
2.12.2 US WorldMeds Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 US WorldMeds SWOT Analysis
2.12.4 US WorldMeds Product and Services
2.12.5 US WorldMeds Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.13 Endo Pharmaceuticals
2.13.1 Endo Pharmaceuticals Details
2.13.2 Endo Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Endo Pharmaceuticals SWOT Analysis
2.13.4 Endo Pharmaceuticals Product and Services
2.13.5 Endo Pharmaceuticals Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.14 Orion
2.14.1 Orion Details
2.14.2 Orion Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Orion SWOT Analysis
2.14.4 Orion Product and Services
2.14.5 Orion Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.15 Valeant
2.15.1 Valeant Details
2.15.2 Valeant Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Valeant SWOT Analysis
2.15.4 Valeant Product and Services
2.15.5 Valeant Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.16 F.Hoffmann-La Roche
2.16.1 F.Hoffmann-La Roche Details
2.16.2 F.Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 F.Hoffmann-La Roche SWOT Analysis
2.16.4 F.Hoffmann-La Roche Product and Services
2.16.5 F.Hoffmann-La Roche Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.17 Bausch Health
2.17.1 Bausch Health Details
2.17.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Bausch Health SWOT Analysis
2.17.4 Bausch Health Product and Services
2.17.5 Bausch Health Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.18 Stada Arzneimittel
2.18.1 Stada Arzneimittel Details
2.18.2 Stada Arzneimittel Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Stada Arzneimittel SWOT Analysis
2.18.4 Stada Arzneimittel Product and Services
2.18.3 Stada Arzneimittel Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.19 H.Lundbeck
2.19.1 H.Lundbeck Details
2.19.2 H.Lundbeck Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 H.Lundbeck SWOT Analysis
2.19.4 H.Lundbeck Product and Services
2.19.5 H.Lundbeck Parkinson Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Parkinson Disease Drug Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Parkinson Disease Drug Players Market Share
3.2.2 Top 10 Parkinson Disease Drug Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Parkinson Disease Drug Revenue and Market Share by Regions
4.2 North America Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
4.3 Europe Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
4.5 South America Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
5 North America Parkinson Disease Drug Revenue by Countries
5.1 North America Parkinson Disease Drug Revenue by Countries (2015-2020)
5.2 USA Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
5.3 Canada Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
5.4 Mexico Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
6 Europe Parkinson Disease Drug Revenue by Countries
6.1 Europe Parkinson Disease Drug Revenue by Countries (2015-2020)
6.2 Germany Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
6.3 UK Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
6.4 France Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
6.5 Russia Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
6.6 Italy Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Parkinson Disease Drug Revenue by Countries
7.1 Asia-Pacific Parkinson Disease Drug Revenue by Countries (2015-2020)
7.2 China Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
7.3 Japan Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
7.4 Korea Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
7.5 India Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
8 South America Parkinson Disease Drug Revenue by Countries
8.1 South America Parkinson Disease Drug Revenue by Countries (2015-2020)
8.2 Brazil Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
8.3 Argentina Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Parkinson Disease Drug by Countries
9.1 Middle East & Africa Parkinson Disease Drug Revenue by Countries (2015-2020)
9.2 Saudi Arabia Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
9.3 UAE Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
9.4 Egypt Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
9.5 South Africa Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Parkinson Disease Drug Revenue and Market Share by Type (2015-2020)
10.2 Global Parkinson Disease Drug Market Forecast by Type (2019-2024)
10.3 Sinemet-CR Revenue Growth Rate (2015-2025)
10.4 Trastal Revenue Growth Rate (2015-2025)
10.5 Madopar Revenue Growth Rate (2015-2025)
10.6 COMT Inhibitor Revenue Growth Rate (2015-2025)
10.7 Other Revenue Growth Rate (2015-2025)
11 Global Parkinson Disease Drug Market Segment by Application
11.1 Global Parkinson Disease Drug Revenue Market Share by Application (2015-2020)
11.2 Parkinson Disease Drug Market Forecast by Application (2019-2024)
11.3 Under 40 Years Old Revenue Growth (2015-2020)
11.4 40-65 Years Old Revenue Growth (2015-2020)
11.5 Above 65 Years Old Revenue Growth (2015-2020)
12 Global Parkinson Disease Drug Market Size Forecast (2021-2025)
12.1 Global Parkinson Disease Drug Market Size Forecast (2021-2025)
12.2 Global Parkinson Disease Drug Market Forecast by Regions (2021-2025)
12.3 North America Parkinson Disease Drug Revenue Market Forecast (2021-2025)
12.4 Europe Parkinson Disease Drug Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Parkinson Disease Drug Revenue Market Forecast (2021-2025)
12.6 South America Parkinson Disease Drug Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Parkinson Disease Drug Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global Parkinson Disease Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Parkinson Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Parkinson Disease Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Parkinson Disease Drug Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Merck Corporate Information, Location and Competitors
Table 6. Merck Parkinson Disease Drug Major Business
Table 7. Merck Parkinson Disease Drug Total Revenue (USD Million) (2017-2018)
Table 8. Merck SWOT Analysis
Table 9. Merck Parkinson Disease Drug Product and Solutions
Table 10. Merck Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Kyowa Hakko Kirin Pharma Corporate Information, Location and Competitors
Table 12. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Major Business
Table 13. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Total Revenue (USD Million) (2018-2019)
Table 14. Kyowa Hakko Kirin Pharma SWOT Analysis
Table 15. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product and Solutions
Table 16. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Novartis Corporate Information, Location and Competitors
Table 18. Novartis Parkinson Disease Drug Major Business
Table 19. Novartis Parkinson Disease Drug Total Revenue (USD Million) (2017-2018)
Table 20. Novartis SWOT Analysis
Table 21. Novartis Parkinson Disease Drug Product and Solutions
Table 22. Novartis Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Akorn Corporate Information, Location and Competitors
Table 24. Akorn Parkinson Disease Drug Major Business
Table 25. Akorn Parkinson Disease Drug Total Revenue (USD Million) (2017-2018)
Table 26. Akorn SWOT Analysis
Table 27. Akorn Parkinson Disease Drug Product and Solutions
Table 28. Akorn Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Abbvie Corporate Information, Location and Competitors
Table 30. Abbvie Parkinson Disease Drug Major Business
Table 31. Abbvie Parkinson Disease Drug Total Revenue (USD Million) (2017-2018)
Table 32. Abbvie SWOT Analysis
Table 33. Abbvie Parkinson Disease Drug Product and Solutions
Table 34. Abbvie Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. GSK Corporate Information, Location and Competitors
Table 36. GSK Parkinson Disease Drug Major Business
Table 37. GSK Parkinson Disease Drug Total Revenue (USD Million) (2017-2018)
Table 38. GSK SWOT Analysis
Table 39. GSK Parkinson Disease Drug Product and Solutions
Table 40. GSK Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Desitin Arzneimittel Corporate Information, Location and Competitors
Table 42. Desitin Arzneimittel Parkinson Disease Drug Major Business
Table 43. Desitin Arzneimittel Parkinson Disease Drug Total Revenue (USD Million) (2017-2018)
Table 44. Desitin Arzneimittel SWOT Analysis
Table 45. Desitin Arzneimittel Parkinson Disease Drug Product and Solutions
Table 46. Desitin Arzneimittel Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Teva Pharmaceutical Corporate Information, Location and Competitors
Table 48. Teva Pharmaceutical Parkinson Disease Drug Major Business
Table 49. Teva Pharmaceutical Parkinson Disease Drug Total Revenue (USD Million) (2017-2018)
Table 50. Teva Pharmaceutical SWOT Analysis
Table 51. Teva Pharmaceutical Parkinson Disease Drug Product and Solutions
Table 52. Teva Pharmaceutical Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 54. Boehringer Ingelheim Parkinson Disease Drug Major Business
Table 55. Boehringer Ingelheim Parkinson Disease Drug Total Revenue (USD Million) (2017-2018)
Table 56. Boehringer Ingelheim SWOT Analysis
Table 57. Boehringer Ingelheim Parkinson Disease Drug Product and Solutions
Table 58. Boehringer Ingelheim Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Astellas Pharma Corporate Information, Location and Competitors
Table 60. Astellas Pharma Parkinson Disease Drug Major Business
Table 61. Astellas Pharma Parkinson Disease Drug Total Revenue (USD Million) (2017-2018)
Table 62. Astellas Pharma SWOT Analysis
Table 63. Astellas Pharma Parkinson Disease Drug Product and Solutions
Table 64. Astellas Pharma Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Apokyn Corporate Information, Location and Competitors
Table 66. Apokyn Parkinson Disease Drug Major Business
Table 67. Apokyn Parkinson Disease Drug Total Revenue (USD Million) (2017-2018)
Table 68. Apokyn SWOT Analysis
Table 69. Apokyn Parkinson Disease Drug Product and Solutions
Table 70. Apokyn Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. US WorldMeds Corporate Information, Location and Competitors
Table 72. US WorldMeds Parkinson Disease Drug Major Business
Table 73. US WorldMeds Parkinson Disease Drug Total Revenue (USD Million) (2017-2018)
Table 74. US WorldMeds SWOT Analysis
Table 75. US WorldMeds Parkinson Disease Drug Product and Solutions
Table 76. US WorldMeds Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Endo Pharmaceuticals Corporate Information, Location and Competitors
Table 78. Endo Pharmaceuticals Parkinson Disease Drug Major Business
Table 79. Endo Pharmaceuticals Parkinson Disease Drug Total Revenue (USD Million) (2017-2018)
Table 80. Endo Pharmaceuticals SWOT Analysis
Table 81. Endo Pharmaceuticals Parkinson Disease Drug Product and Solutions
Table 82. Endo Pharmaceuticals Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Orion Corporate Information, Location and Competitors
Table 84. Orion Parkinson Disease Drug Major Business
Table 85. Orion Parkinson Disease Drug Total Revenue (USD Million) (2017-2018)
Table 86. Orion SWOT Analysis
Table 87. Orion Parkinson Disease Drug Product and Solutions
Table 88. Orion Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Valeant Corporate Information, Location and Competitors
Table 90. Valeant Parkinson Disease Drug Major Business
Table 91. Valeant Parkinson Disease Drug Total Revenue (USD Million) (2017-2018)
Table 92. Valeant SWOT Analysis
Table 93. Valeant Parkinson Disease Drug Product and Solutions
Table 94. Valeant Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. F.Hoffmann-La Roche Corporate Information, Location and Competitors
Table 96. F.Hoffmann-La Roche Parkinson Disease Drug Major Business
Table 97. F.Hoffmann-La Roche Parkinson Disease Drug Total Revenue (USD Million) (2017-2018)
Table 98. F.Hoffmann-La Roche SWOT Analysis
Table 99. F.Hoffmann-La Roche Parkinson Disease Drug Product and Solutions
Table 100. F.Hoffmann-La Roche Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Bausch Health Corporate Information, Location and Competitors
Table 102. Bausch Health Parkinson Disease Drug Major Business
Table 103. Bausch Health Parkinson Disease Drug Total Revenue (USD Million) (2017-2018)
Table 104. Bausch Health SWOT Analysis
Table 105. Bausch Health Parkinson Disease Drug Product and Solutions
Table 106. Bausch Health Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Stada Arzneimittel Parkinson Disease Drug Type and Application
Table 108. Stada Arzneimittel Parkinson Disease Drug Major Business
Table 109. Stada Arzneimittel Parkinson Disease Drug Total Revenue (USD Million) (2017-2018)
Table 110. Stada Arzneimittel SWOT Analysis
Table 111. Stada Arzneimittel Parkinson Disease Drug Product and Solutions
Table 112. Stada Arzneimittel Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. H.Lundbeck Corporate Information, Location and Competitors
Table 114. H.Lundbeck Parkinson Disease Drug Major Business
Table 115. H.Lundbeck Parkinson Disease Drug Total Revenue (USD Million) (2017-2018)
Table 116. H.Lundbeck SWOT Analysis
Table 117. H.Lundbeck Parkinson Disease Drug Product and Solutions
Table 118. H.Lundbeck Parkinson Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. Global Parkinson Disease Drug Revenue (Million USD) by Players (2015-2020)
Table 120. Global Parkinson Disease Drug Revenue Share by Players (2015-2020)
Table 121. Global Parkinson Disease Drug Revenue (Million USD) by Regions (2015-2020)
Table 122. Global Parkinson Disease Drug Revenue Market Share by Regions (2015-2020)
Table 123. North America Parkinson Disease Drug Revenue by Countries (2015-2020)
Table 124. North America Parkinson Disease Drug Revenue Market Share by Countries (2015-2020)
Table 125. Europe Parkinson Disease Drug Revenue (Million USD) by Countries (2015-2020)
Table 126. Asia-Pacific Parkinson Disease Drug Revenue (Million USD) by Countries (2015-2020)
Table 127. South America Parkinson Disease Drug Revenue by Countries (2015-2020)
Table 128. South America Parkinson Disease Drug Revenue Market Share by Countries (2015-2020)
Table 129. Middle East and Africa Parkinson Disease Drug Revenue (Million USD) by Countries (2015-2020)
Table 130. Middle East and Africa Parkinson Disease Drug Revenue Market Share by Countries (2015-2020)
Table 131. Global Parkinson Disease Drug Revenue (Million USD) by Type (2015-2020)
Table 132. Global Parkinson Disease Drug Revenue Share by Type (2015-2020)
Table 133. Global Parkinson Disease Drug Revenue Forecast by Type (2021-2025)
Table 134. Global Parkinson Disease Drug Revenue by Application (2015-2020)
Table 135. Global Parkinson Disease Drug Revenue Share by Application (2015-2020)
Table 136. Global Parkinson Disease Drug Revenue Forecast by Application (2021-2025)
Table 137. Global Parkinson Disease Drug Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Parkinson Disease Drug Picture
Figure 2. Global Parkinson Disease Drug Revenue Market Share by Type in 2019
Figure 3. Sinemet-CR Picture
Figure 4. Trastal Picture
Figure 5. Madopar Picture
Figure 6. COMT Inhibitor Picture
Figure 7. Other Picture
Figure 8. Parkinson Disease Drug Revenue Market Share by Application in 2019
Figure 9. Under 40 Years Old Picture
Figure 10. 40-65 Years Old Picture
Figure 11. Above 65 Years Old Picture
Figure 12. Global Parkinson Disease Drug Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Parkinson Disease Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Parkinson Disease Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Parkinson Disease Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Parkinson Disease Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Parkinson Disease Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Parkinson Disease Drug Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Parkinson Disease Drug Revenue Market Share in 2019
Figure 21. Global Top 10 Players Parkinson Disease Drug Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Parkinson Disease Drug Revenue Market Share by Regions (2015-2020)
Figure 25. Global Parkinson Disease Drug Revenue Market Share by Regions in 2018
Figure 26. North America Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 27. Europe Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 29. South America Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 31. North America Parkinson Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 32. North America Parkinson Disease Drug Revenue Market Share by Countries in 2019
Figure 33. USA Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 34. Canada Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 36. Europe Parkinson Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Parkinson Disease Drug Revenue Market Share by Countries in 2019
Figure 38. Germany Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 39. UK Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 40. France Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 41. Russia Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 42. Italy Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Parkinson Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Parkinson Disease Drug Revenue Market Share by Countries in 2019
Figure 45. China Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 46. Japan Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 47. Korea Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 48. India Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 50. South America Parkinson Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 51. South America Parkinson Disease Drug Revenue Market Share by Countries in 2019
Figure 52. Brazil Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Parkinson Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Parkinson Disease Drug Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 57. UAE Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Parkinson Disease Drug Revenue and Growth Rate (2015-2020)
Figure 60. Global Parkinson Disease Drug Revenue Share by Type (2015-2020)
Figure 61. Global Parkinson Disease Drug Revenue Share by Type in 2019
Figure 62. Global Parkinson Disease Drug Market Share Forecast by Type (2021-2025)
Figure 63. Global Sinemet-CR Revenue Growth Rate (2015-2020)
Figure 64. Global Trastal Revenue Growth Rate (2015-2020)
Figure 65. Global Madopar Revenue Growth Rate (2015-2020)
Figure 66. Global COMT Inhibitor Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global Parkinson Disease Drug Revenue Share by Application (2015-2020)
Figure 69. Global Parkinson Disease Drug Revenue Share by Application in 2019
Figure 70. Global Parkinson Disease Drug Market Share Forecast by Application (2021-2025)
Figure 71. Global Under 40 Years Old Revenue Growth Rate (2015-2020)
Figure 72. Global 40-65 Years Old Revenue Growth Rate (2015-2020)
Figure 73. Global Above 65 Years Old Revenue Growth Rate (2015-2020)
Figure 74. Global Parkinson Disease Drug Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Parkinson Disease Drug Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Parkinson Disease Drug Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Parkinson Disease Drug Revenue Market Forecast (2021-2025)
Figure 78. Europe Parkinson Disease Drug Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Parkinson Disease Drug Revenue Market Forecast (2021-2025)
Figure 80. South America Parkinson Disease Drug Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Parkinson Disease Drug Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets